Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2 1Phase 1 1

Status

Completed 12Terminated 10Recruiting 6Withdrawn 5Unknown 5Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6CNS 4Other solid neoplasm 3Head & Neck 3Dermatologic 3Breast 3Sarcoma 2Other hematologic neoplasm 2Other 2Gynecologic 2Gastrointestinal 2Thoracic 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Prostate Cancer Recurrent 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Castration Sensitive Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 87Specimen Handling 76pembrolizumab 74enzalutamide 57Radiosurgery 57Radiotherapy 51Docetaxel 50Androgen Antagonists 48Gemcitabine 43Nivolumab 40darolutamide 39Prednisone 35Abiraterone Acetate 33enfortumab vedotin 32Biopsy 31Cisplatin 30Carboplatin 29apalutamide 28Standard of Care 28cabozantinib 27Pluvicto 27abiraterone 26Blood Specimen Collection 25Radiation 23Leuprolide 23Ipilimumab 23X-Rays 18relugolix 17Triptorelin Pamoate 17Surveys and Questionnaires 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Metformin × Genitourinary × Clear all
NCT05515978 2026-06-02

PragMet

University of Colorado, Denver

Phase EARLY_PHASE1 Recruiting
100 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05036226 2026-05-13

COAST

Medical University of South Carolina

Phase 1/2 Recruiting
76 enrolled
GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT06044025 2026-01-15

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

University of Arkansas

Phase 1 Recruiting
34 enrolled
Genitourinary

Castration Sensitive Prostate Cancer

NCT04536805 2025-12-08

REPAIR

Institut Cancerologie de l'Ouest

Phase 1/2 Recruiting
44 enrolled
Genitourinary

Prostatic Neoplasms

NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Cairo University

Phase 4 Recruiting
78 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03379909 2023-09-21

TROJAN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Recruiting
49 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡